October 2020
Food and Drug Administration (FDA)
“III. Criteria and Considerations for the Issuance of an EUA for a COVID-19 Vaccine… Based on this declaration and determination, FDA may issue an EUA after FDA has determined that the following statutory requirements are met (section 564 of the FD&C Act (21 U.S.C. 360bbb-3)) (Ref. 3): …
- There is no adequate, approved, and available alternative to the product for diagnosing, preventing, or treating the disease or condition.”
Works of the United States government are not entitled to domestic copyright protection under U.S. law and are therefore in the public domain.
document
COVID-19,emergency use authorization (EUA),FDA approvals,manufacturers,vaccines